Post date February 14, 2024 Experience Cigna $4.5 billion senior notes offering The senior notes are due 2029, 2031, 2034 and 2054
Post date February 13, 2024 Experience Metagenomi $93.75 million IPO The shares are listed on the Nasdaq Global Market
Post date February 5, 2024 Experience Immunocore Holdings $402.5 million convertible notes offering The 2.5% convertible notes are due 2030
Post date November 16, 2023 Experience Spirit AeroSystems $460 million stock and exchangeable notes offering The stock is listed on the New York Stock Exchange
Post date November 14, 2023 Experience Bristol Myers Squibb $4.5 billion notes offering The investment-grade offering comprised four tranches
Post date September 14, 2023 Experience Arm $4.87 billion IPO The deal is the largest U.S. IPO since November 2021
Post date September 12, 2023 Experience Marsh McLennan $1.6 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering
Post date July 28, 2023 Experience Banc of California merger with PacWest and $400 million equity raise We are advising JPMorgan as financial adviser and placement agent to Banc of California
Post date June 20, 2023 Experience Editas Medicine $125 million follow-on offering The stock is listed on the Nasdaq Global Select Market
Post date June 13, 2023 Experience Ventas Realty $862.5 million exchangeable senior notes offering We advised Ventas on the transaction